ECSP044985A - Azitromicina de dosis única para infecciones respiratorias - Google Patents

Azitromicina de dosis única para infecciones respiratorias

Info

Publication number
ECSP044985A
ECSP044985A EC2004004985A ECSP044985A ECSP044985A EC SP044985 A ECSP044985 A EC SP044985A EC 2004004985 A EC2004004985 A EC 2004004985A EC SP044985 A ECSP044985 A EC SP044985A EC SP044985 A ECSP044985 A EC SP044985A
Authority
EC
Ecuador
Prior art keywords
single dose
respiratory infections
azithromycin
dose azithromycin
infections
Prior art date
Application number
EC2004004985A
Other languages
English (en)
Inventor
Michael William Dunne
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ECSP044985A publication Critical patent/ECSP044985A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a un procedimiento de infecciones respiratorias en humanos administrando una dosis única de azitromicina
EC2004004985A 2001-08-21 2004-02-20 Azitromicina de dosis única para infecciones respiratorias ECSP044985A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21

Publications (1)

Publication Number Publication Date
ECSP044985A true ECSP044985A (es) 2004-04-28

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004004985A ECSP044985A (es) 2001-08-21 2004-02-20 Azitromicina de dosis única para infecciones respiratorias

Country Status (25)

Country Link
US (3) US20030148964A1 (es)
EP (1) EP1418924A2 (es)
JP (1) JP2005501862A (es)
KR (1) KR20040032942A (es)
AP (1) AP1729A (es)
BG (1) BG108537A (es)
BR (1) BR0211830A (es)
CA (1) CA2458135A1 (es)
CZ (1) CZ2004232A3 (es)
EA (1) EA200400214A1 (es)
EC (1) ECSP044985A (es)
GE (1) GEP20063812B (es)
HR (1) HRP20040163A2 (es)
HU (1) HUP0401332A2 (es)
IL (1) IL159585A0 (es)
IS (1) IS7092A (es)
MA (1) MA27059A1 (es)
MX (1) MXPA04001605A (es)
OA (1) OA12845A (es)
PL (1) PL367888A1 (es)
SK (1) SK1012004A3 (es)
TN (1) TNSN04035A1 (es)
WO (1) WO2003018031A2 (es)
YU (1) YU8804A (es)
ZA (1) ZA200400804B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572773B2 (en) * 2003-07-24 2009-08-11 Pliva Hrvatska D.O.O. Single dose fast dissolving azithromycin
EP1691786A1 (en) 2003-12-04 2006-08-23 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053656A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
JP2007513145A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
EP3718532A1 (en) 2005-12-08 2020-10-07 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
WO2009114810A2 (en) * 2008-03-14 2009-09-17 The Florida International Uinversity Board Of Trustees Use of ellagitannins as inhibitors of bacterial quorum sensing
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
PL3466432T3 (pl) 2014-05-15 2021-02-08 Insmed Incorporated Sposoby leczenia zakażeń płuc niegruźliczymi mykobakteriami
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
EP4103725A4 (en) * 2020-02-14 2024-03-27 Asklepios Biopharmaceutical, Inc. METHOD FOR TREATING GENE THERAPY-ASSOCIATED TOXICITY WITH ANTIBIOTICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (en) 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
YU45590A (sh) 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (es) 1992-07-30 1996-03-01 Pfizer
ES2104386T3 (es) 1993-05-19 1997-10-01 Pfizer Compuesto intermedio para la acitromicina.
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
EP0758244B2 (en) 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
OA12845A (en) 2006-09-15
KR20040032942A (ko) 2004-04-17
US6987093B2 (en) 2006-01-17
EP1418924A2 (en) 2004-05-19
ZA200400804B (en) 2005-05-03
AP2004002968A0 (en) 2004-03-31
BR0211830A (pt) 2004-09-08
US20030148964A1 (en) 2003-08-07
MA27059A1 (fr) 2004-12-20
GEP20063812B (en) 2006-05-10
TNSN04035A1 (fr) 2006-06-01
YU8804A (sh) 2006-08-17
IS7092A (is) 2003-12-23
US7067493B2 (en) 2006-06-27
US20050250712A1 (en) 2005-11-10
HRP20040163A2 (en) 2005-02-28
HUP0401332A2 (hu) 2004-11-29
MXPA04001605A (es) 2004-07-08
US20040023898A1 (en) 2004-02-05
WO2003018031A3 (en) 2003-10-02
PL367888A1 (en) 2005-03-07
EA200400214A1 (ru) 2004-06-24
JP2005501862A (ja) 2005-01-20
IL159585A0 (en) 2004-06-01
CA2458135A1 (en) 2003-03-06
WO2003018031A2 (en) 2003-03-06
BG108537A (bg) 2005-02-28
CZ2004232A3 (cs) 2005-10-12
SK1012004A3 (sk) 2005-04-01
AP1729A (en) 2007-03-26

Similar Documents

Publication Publication Date Title
ECSP044985A (es) Azitromicina de dosis única para infecciones respiratorias
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
CY1106774T1 (el) Συνθεσεις φαρμακευτικων μεσων με βαση αλατα του τιοτροπιου και αλατα της σαλμετερολης
DK1307227T3 (da) Farmaceutiske sammensætninger
LTPA2014019I1 (lt) Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
CY1106283T1 (el) Κινολινυλ-πυρρολοπυραζολες
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
UY26269A1 (es) Formulación de sal común y moxifloxacina
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
NO20043115L (no) Substituerte diketopiperaziner som oksytocin antagonister
ECSP034561A (es) Derivados puente de piperazina
BRPI0410044B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
BRPI0317188A2 (pt) Novo derivado de 2,4-diamino-1,3,5-triazina
SE0004101D0 (sv) New use
CY1106712T1 (el) Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
DE60322395D1 (de) Antipruritisches mittel
SE0004827D0 (sv) Therapeutic compounds
HN2001000214A (es) Alcanosulfonatos de fenoxifenilo